iSpecimen
ISPC
10 hedge funds and large institutions have $9.21M invested in iSpecimen in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
72% more capital invested
Capital invested by funds: $5.35M → $9.21M (+$3.87M)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
25% more funds holding
Funds holding: 8 → 10 (+2)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$811K |
| 2 |
EGM
Engineers Gate Manager
New York
|
+$244K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$122K |
| 4 |
MSFS
Main Street Financial Solutions
Newtown,
Pennsylvania
|
+$93.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$93.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
-$2.48M |
| 2 |
KC
Kepos Capital
New York
|
-$309K |
| 3 |
Millennium Management
New York
|
-$162K |
| 4 |
TC
Telemus Capital
Southfield,
Michigan
|
-$142K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$74K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EAM
1
Empery Asset Management
New York
| $3.64M | +$4.18M | +583 | New |
|
|
BL
2
Bleichroeder LP
New York
| $2.83M | -$2.48M | -345 | -45% |
|
|
KC
3
Kepos Capital
New York
| $1.48M | -$309K | -43 | -15% |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $709K | +$811K | +113 | New |
|
|
EGM
5
Engineers Gate Manager
New York
| $211K | +$244K | +34 | New |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $103K | +$122K | +17 | New |
|
|
MSFS
7
Main Street Financial Solutions
Newtown,
Pennsylvania
| $82K | +$93.3K | +13 | New |
|
|
TSS
8
Two Sigma Securities
New York
| $79K | +$93.3K | +13 | New |
|
9
BlackRock
New York
| $56K | +$7.18K | +1 | +13% |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $21K | +$7.18K | +1 | +50% |
|
|
11
Millennium Management
New York
| – | -$162K | -35 | Closed |
|
|
TC
12
Telemus Capital
Southfield,
Michigan
| – | -$142K | -31 | Closed |
|
|
13
Citadel Advisors
Miami,
Florida
| – | -$74K | -16 | Closed |
|
|
TCWM
14
Total Clarity Wealth Management
St. Charles,
Illinois
| – | -$5K | -1 | Closed |
|
ISPC Hedge Fund Activity: Q4 2021 in Review
10 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q4 2021, worth a combined $9.21M — up 72% from $5.35M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ISPC positions and 4 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $811K. The largest seller was Bleichroeder LP, cutting an estimated $2.48M.
- 10 institutional investors held iSpecimen (ISPC) as of Q4 2021, up from 8 in Q3 2021.
- Funds reported $9.21M of iSpecimen stock for Q4 2021, up 72% quarter-over-quarter.
- 6 funds opened new iSpecimen positions in Q4 2021 and 4 closed out, a net change of +2 holders.
- The largest iSpecimen buyer in Q4 2021 was Vanguard Group, an estimated $811K added.
- The largest iSpecimen seller in Q4 2021 was Bleichroeder LP, an estimated $2.48M sold.
Based on aggregated 13F filings for Q4 2021.